Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is AstraZeneca a Bad-News Buy?

TheMotleyFool

0 0

AstraZeneca (NASDAQ: AZN) was once viewed as one of the biggest potential winners in the COVID-19 vaccine race. Now, though, the company's vaccine program has been bogged down links to blood clotting issues. In this Motley Fool Live video recorded on April 14, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not the big pharma stock could be a bad news buy.

Source Fool.com

Like: 0

AZN

Share